Ultralife

Ultralife Corp. engages in the manufacture and sale of products for power solutions. It operates through the Battery & Energy Products and Communications System segments. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, thin cell and various other non-rechargeable batteries, in addition to rechargeable batteries, uninterruptable power supplies, charging systems, and accessories such as cables. The Communications System segment comprises radio frequency amplifiers, power supplies, cable and connector assemblies, amplified speakers, equipment mounts, case equipment, integrated communication systems for fixed or vehicle applications, and communications and electronics systems design. The company was founded by Arthur M. Liberman in December 1990 and is headquartered in Newark, NY.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Ultralife Corporation reports resilient Q1 performance amidst cyber attack impact

Ultralife Corporation's Q1 2023 performance showcased resilience in the face of operational challenges, with a focus on improving margins and addressing supply chain issues. The impact of the cyber attack and ongoing initiatives to enhance profitability were key discussion points, highlighting the company's proactive stance in navigating challenges and pursuing growth opportunities.

ULBI reports impressive Q2 2023 performance and anticipates strong Q3 earnings

ULBI's Q2 2023 earnings call showcased robust financial performance, a strong backlog, and strategic initiatives to drive growth. While facing challenges in cyber-attack recovery and supply chain improvements, the company is well-positioned to capitalize on organic growth opportunities.

ULBI reports strong Q3 performance, eyes growth in diverse markets

ULBI's Q3 2023 performance reflects strong revenue growth, margin improvement, and a focus on organic growth opportunities. The company faces challenges in managing debt while investing in growth initiatives but has opportunities for expansion in various markets. Overall, ULBI's performance and strategic focus position it for future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEWARK, N.Y., April 25, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the first quarter ended March 31, 2024 with the following highlights:

Ultralife Corporation Reports First Quarter Results

ULBI is likely to deliver above-market returns in the next two years, with improving fundamentals and a modest valuation. They should benefit from growth in the battery market and increased military spending. Management is delivering on growth and margin improvement; EPS could double in 2024.

Ultralife Corporation: Ready To Surge

NEWARK, N.Y., April 11, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2024 before the market opens on Thursday, April 25, 2024.

Ultralife Corporation to Report First Quarter Results on April 25, 2024

Ultralife Corporation (ULBI) Q4 2023 Earnings Call Transcript

NEWARK, N.Y., Feb. 15, 2024 (GLOBE NEWSWIRE) --  Ultralife Corporation (NASDAQ:   ULBI) reported operating results for the fourth quarter and full year ended December 31, 2023.

Ultralife Corporation Reports Fourth Quarter Results

NEWARK, N.Y., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2023 before the market opens on Thursday, February 15, 2024.

Ultralife Corporation to Report Fourth Quarter Results on February 15, 2024

Ultralife Corporation shares have experienced a pullback of over 30%, making it an attractive investment opportunity. ULBI focuses on margin improvement and growing sales, with plans to pay down debt and evaluate further takeover targets. The company's range of new products and innovations is expected to drive revenue to new highs in FY2023 and beyond.

Ultralife: Buy The Dip

Ultralife Corporation (NASDAQ:ULBI ) Q3 2023 Earnings Conference Call October 26, 2023 8:30 AM ET Company Participants Jody Burfening - Investor Relations Michael Manna - President & Chief Executive Officer Philip Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - Benchmark Company Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation Third Quarter 2020 Results Conference Call.

Ultralife Corporation (ULBI) Q3 2023 Earnings Call Transcript

NEWARK, N.Y., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2023 with the following highlights:

Ultralife Corporation Reports Third Quarter Results

NEWARK, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2023 before the market opens on Thursday, October 26, 2023.

Ultralife Corporation to Report Third Quarter Results on October 26, 2023

Ultralife's strong revenue and earnings growth can drive the stock to above-average gains. The valuation is reasonable, leaving room for upside for the stock. Ultralife is poised to benefit over multiple years from the expected industry growth for lithium-ion batteries.

Ultralife: Stock To Outperform With Growth From Multiple Industries

Ultralife manufactures portable power solutions and communication systems for a range of industries. The company has put in place certain initiatives that could lead to gross margin progression this year and next. Investors are advised to wait for a pullback in the price action, considering the current risk-reward on the charts.

Ultralife Corporation: On The Up, But Wait For A Better Entry Point

Ultralife Corporation reports an impressive increase in backlog, indicating potential for future net sales growth. Communications Systems segment shows significant revenue growth, driven by demand from government, defense, and medical customers. Market analysts have positive expectations for Ultralife, with projected growth in net sales, EBITDA, and net income.

Ultralife: Backlog Increase And FCF Growth Imply Undervaluation

Ultralife Corporation (NASDAQ:ULBI ) Q2 2023 Earnings Conference Call July 27, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna - President and CEO Philip Fain - CFO Conference Call Participants Joshua Sullivan - The Benchmark Company Operator Good day and thank you for standing by. Welcome to the Ultralife Earnings Conference Call.

Ultralife Corporation (ULBI) Q2 2023 Earnings Call Transcript

NEWARK, N.Y., July 27, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2023 with the following highlights:

Ultralife Corporation Reports Second Quarter Results

NEWARK, N.Y., July 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its second quarter results for the period ended June 30, 2023 before the market opens on Thursday, July 27, 2023.

Ultralife Corporation to Report Second Quarter Results on July 27, 2023

Ultralife Corporation (NASDAQ:ULBI ) Q1 2023 Earnings Conference Call April 27, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna - President and CEO Philip Fain - CFO Conference Call Participants Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation First Quarter 2023 Results Conference Call.

Ultralife Corporation (ULBI) Q1 2023 Results - Earnings Call Transcript

NEWARK, N.Y., April 13, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its first quarter results for the period ended March 31, 2023 before the market opens on Thursday, April 27, 2023.

Ultralife Corporation to Report First Quarter Results on April 27, 2023

Ultralife Corporation (NASDAQ:ULBI ) Q4 2022 Earnings Conference Call March 2, 2023 8:30 AM ET Company Participants Jody Burfening - IR Michael Manna - President and CEO Philip Fain - CFO Conference Call Participants Josh Sullivan - Benchmark Company John Deysher - Pinnacle Operator Good day, and thank you for standing by. Welcome to the Ultralife Corporation Fourth Quarter 2022 Results Conference Call.

Ultralife Corporation (ULBI) Q4 2022 Earnings Call Transcript

NEWARK, N.Y., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) announced today the addition of Janie Goddard as Director of the Company.

Ultralife Corporation Adds Janie Goddard to its Board of Directors

NEWARK, N.Y., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its fourth quarter results for the period ended December 31, 2022 before the market opens on Thursday, March 2, 2023. We are reporting our quarterly results later than our customary reporting practice due to illnesses experienced by some members of our Accounting/Finance Team causing delays in the year-end closing and audit.

Ultralife Corporation to Report Fourth Quarter Results on March 2, 2023

NEWARK, N.Y., Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Board of Directors of Ultralife Corporation (“Ultralife” or the “Company”) (NASDAQ: ULBI) has appointed Michael E. Manna as the Company's President & CEO and as a member of the Board of Directors effective immediately to replace Michael D. Popielec who is leaving the Company. Mr. Popielec will remain with Ultralife as an employee for a sixty-day period ending January 20, 2023 in an advisory role to ensure a smooth leadership transition. In addition to his new role, Mike Manna will retain his leadership position for the Company's Battery & Energy Products segment which he held prior to his appointment as President & CEO.

Ultralife Corporation Names Michael E. Manna President & CEO

Ultralife Corporation (NASDAQ:ULBI ) Q3 2022 Earnings Conference Call October 27, 2022 8:30 AM ET Company Participants Jody Burfening - Investor Relations Michael Popielec - President and Chief Executive Officer Philip Fain - Chief Financial Officer Conference Call Participants Josh Sullivan - The Benchmark Company, LLC Operator Hello and welcome to Ultralife Corporation Third Quarter 2022 Earnings Release. My name is Pricilla and I will be your coordinator for today's event.

Ultralife Corporation (ULBI) CEO Michael Popielec on Q3 2022 Results - Earnings Call Transcript

NEWARK, N.Y., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has been awarded a purchase order valued at approximately $5.5 million to supply its vehicle communications systems to a global prime defense contractor for the U.S. Army. Ultralife's vehicle communications platform provides the soldier with an enhanced range of digital voice and data communications and operational flexibility. Shipments are expected to commence and be completed in 2023.

Ultralife Corporation Receives $5.5 Million Communications Systems Contract

NEWARK, N.Y., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) will report its third quarter results for the period ended September 30, 2022, before the market opens on Thursday, October 27, 2022.

News for Ultralife Stock (ULBI)